Speaker illustration

Doctor Motoki Nakao

Hokkaido University, Sapporo (Japan)

Small left ventricular size predicts implantable cardioverter defibrillator therapy in long-term observation of patients with left ventricular assist device for non-ischemic cardiomyopathy

Event: EHRA 2021

Topic: Epidemiology, Prognosis, Outcome

Session: ePoster session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb